NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/28/2025
Back to search
Official data from USPTO
ARRIVE THERAPY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
22
Latest update
01/28/2025
Trademark type
Combined
Nice classes
44
Filing date
05/09/2021
Registration date
01/28/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/28/2025
Last transaction
01/28/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
09/11/2019
First use in commerce
09/11/2019
Drawing code
5
Owner type
03
Owner location
Paoli, PA, US
Examiner
FOSTER, ALEXANDRA M.
Law office
M80
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of the term "ARRIVE THERAPY" with "ARRIVE" in larger lettering and "THERAPY" in smaller lettering placed below the letters "IVE".
Holders and representatives
Holders
A. T. (pessoa física)
Representatives
Adam G. Garson Lipton, Weinberger & Husick
Technical classification
Nice Classes
Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 44
Psychological counselingpsychotherapymental health counselinggender counseling in the nature of mental health counseling as it relates to genderLGBTQ counseling in the nature of mental health counseling as it relates to LGBTQ identity
Publications
History of USPTO decisions and trademark events.
22 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
01/28/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/10/2024
PUBO
PUBLISHED FOR OPPOSITION
12/10/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/04/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/14/2024
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
05/08/2024
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
11/07/2023
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
05/05/2023
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
11/01/2022
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
04/06/2022
GNSL
LETTER OF SUSPENSION E-MAILED
04/06/2022
CNSL
SUSPENSION LETTER WRITTEN
04/06/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/01/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/31/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/31/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/18/2022
GNRT
NON-FINAL ACTION E-MAILED
01/18/2022
CNRT
NON-FINAL ACTION WRITTEN
01/18/2022
DOCK
ASSIGNED TO EXAMINER
01/12/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/11/2021
NWAP
NEW APPLICATION ENTERED
05/12/2021
Continuous trademark protection
Get notified about every new filing that threatens ARRIVE THERAPY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.